may be slimming, the ripple effects are expanding into nearly every corner of the economy
Fluorescent probes encapsulated in disulfide-conjugated carriers release dyes like ICG in GSH-rich tumors [101]
GLP- 1 Receptor Agonists in Combination with Insulin The GLP- 1 receptor agonists have been shown to improve blood glucose control when used in conjunction with insulin, particularly basal insulin, and may be particularly useful in the treatment of advanced T2DM [108]
Neither compound has published the kind of long-term hard-outcome data (cardiovascular events, mortality) that ultimately defines a metabolic drugs value, because both are too early in development for that
There needs to be more research, said Beattie
Second, many of the included studies relied on region-of-interest (ROI) analyses, which, while offering increased sensitivity for detecting effects in a priori specified regions, may inflate the apparent consistency of findings when aggregated across studies